Creo Medical Group PLC (CREO) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
Creo Medical Group PLC (CREO) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting GBX0.00 (capex GBX0.00 ) from operating cash flow of GBX15.60 Million. See CREO equity financing ratio to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
GBX0.00
Capex + Investments
Operating Cash Flow
GBX15.60 Million
GBX
Capital Expenditures
GBX0.00
GBX
Annual Cash Flow Reinvestment Rate for Creo Medical Group PLC (None–None)
Year-by-year capital reinvestment analysis for Creo Medical Group PLC. For live market cap and broader valuation context, see CREO company net worth.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow